DOI QR코드

DOI QR Code

Pheochromocytoma associated with cyanotic congenital heart disease

청색증형 선천성 심질환에 동반된 갈색세포종

  • Chung, Seung Joon (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Lee, Young Ah (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Shin, Choong Ho (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Yang, Sei Won (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Bae, Eun Jung (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Noh, Jung Il (Department of Pediatrics, College of Medicine, Seoul National University)
  • 정승준 (서울대학교 의과대학 소아과학교실) ;
  • 이영아 (서울대학교 의과대학 소아과학교실) ;
  • 신충호 (서울대학교 의과대학 소아과학교실) ;
  • 양세원 (서울대학교 의과대학 소아과학교실) ;
  • 배은정 (서울대학교 의과대학 소아과학교실) ;
  • 노정일 (서울대학교 의과대학 소아과학교실)
  • Received : 2007.09.03
  • Accepted : 2007.10.22
  • Published : 2008.01.15

Abstract

Pheochromocytoma is a rare tumor of childhood, arising from adrenal medullary and chromaffin tissue. Because chronic hypoxia may induce pheochromocytoma, there have been several reports of pheochromocytoma development in cyanotic patients after corrective or palliative cardiac surgery. The variable clinical presentation of pheochromocytoma is obscured by both underlying heart disease and medications. If sudden hypertension, aggravation of a heart condition, or unusual symptoms such as diabetes mellitus develops in a cyanotic patient with congenital heart disease, pheochromocytoma must be ruled out. We report two patients presenting with cyanotic single-ventricle heart disease with pheochromocytoma.

갈색세포종은 부신 수질과 크롬친화성 조직에서 발생하는 소아기에는 드문 종양이다. 갈색세포종은 저산소증 상태와 연관이 있어, 단심실성 심장질환 수술 후에도 청색증이 지속되는 환자에서 병발하는 경우가 드물게 보고되고 있다. 갈색세포종의 증상이 애매할 뿐만 아니라 심장 질환 또는 치료 약제에 의하여 전형적인 증상들이 나타나지 않을 수 있다. 청색증형 선천성 심질환 환자에서 갑작스런 고혈압, 심장 상태의 악화, 또는 당뇨병 등을 포함한 애매한 증상들이 나타나는 경우에는 갈색세포종을 감별 진단하여야 한다. 저자들은 선천성 단심실성 심장질환과 갈색세포종이 동반된 2례를 보고한다.

Keywords

References

  1. Reisch N, Peczkowska M, Januszewicz A, Neumann HP. Pheochromocytoma: presentation, diagnosis and treatment. J Hypertens 2006;24:2331-9 https://doi.org/10.1097/01.hjh.0000251887.01885.54
  2. Kita T, Imamura T, Date H, Kitamura K, Moriguchi S, Sato Y, et al. Two cases of pheochromocytoma associated with tetralogy of Fallot. Hypertens Res 2003;26:433-7 https://doi.org/10.1291/hypres.26.433
  3. Folger GM Jr, Roberts WC, Mehrizi A, Shah KD, Glancy DL, Carpenter CC, et al. Cyanotic malformations of the heart with pheochromocytoma: a report of five cases. Circulation 1964;29:750-7
  4. de la Monte SM, Hutchins GM, Moore GW. Peripheral neuroblastic tumors and congenital heart disease: possible role of hypoxic states in tumor induction. Am J Pediatr Hematol Oncol 1985;7:109-16
  5. Bravo EL. Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 1994;15:356-68 https://doi.org/10.1210/edrv-15-3-356
  6. Bhansali A, Rajput R, Behra A, Rao KL, Khandelwal N, Radotra BD. Childhood sporadic pheochromocytoma: clinical profile and outcome in 19 patients. J Pediatr Endocrinol Metab 2006;19:749-56
  7. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-900 https://doi.org/10.1016/S0735-1097(02)01886-7
  8. Lee JH, Shim GH, Shin KS, Hong JY, Kim YW, Kim SH, et al. Congenital heart disease in Jeju: postnatal incidence and clinical features. Korean J Pediatr 2004;47:294-303
  9. avia G, Lumachi F, Polistina F, D'Amico DF. Pheochromocytoma, a rare cause of hypertension: long-term follow-up of 55 surgically treated patients. World J Surg 1998;22:689-94 https://doi.org/10.1007/s002689900454
  10. Reynolds JL, Gilchrist TF. Congenital heart disease and pheochromocytoma. Am J Dis Child 1966;112:251-5
  11. Kobayashi S, Millhorn DE. Hypoxia regulates glutamate metabolism and membrane transport in rat PC12 cells. J Neurochem 2001;76:1935-48 https://doi.org/10.1046/j.1471-4159.2001.00214.x
  12. Tyurin VA, Tyurina YY, Quinn PJ, Schor NF, Balachandran R, Day BW, et al. Glutamate-induced cytotoxicity in PC12 pheochromocytoma cells: role of oxidation of phospholipids, glutathione and protein sulfhydryls revealed by bcl-2 transfection. Brain Res Mol Brain Res 1998;60:270-81 https://doi.org/10.1016/S0169-328X(98)00181-8
  13. Seta KA, Spicer Z, Yuan Y, Lu G, Millhorn DE. Responding to hypoxia: lessons from a model cell line. Sci STKE 2002;20:RE11
  14. Freeland K, Boxer LM, Latchman DS. The cyclic AMP response element in the Bcl-2 promoter confers inducibility by hypoxia in neuronal cells. Brain Res Mol Brain Res 2001;92:98-106 https://doi.org/10.1016/S0169-328X(01)00158-9
  15. Sparks JW, Seefelder C, Shamberger RC, McGowan FX. The perioperative management of a patient with complex single ventricle physiology and pheochromocytoma. Anesth Analg 2005;100:972-5 https://doi.org/10.1213/01.ANE.0000146433.84742.3A
  16. Agarwal A, Gupta S, Mishra AK, Singh N, Mishra SK. Normotensive pheochromocytoma: institutional experience. World J Surg 2005;29:1185-8 https://doi.org/10.1007/s00268-005-7839-4
  17. Stenstrom G, Sjostrom L, Smith U. Diabetes mellitus in phaeochromocytoma. Fasting blood glucose levels before and after surgery in 60 patients with phaeochromocytoma. Acta Endocrinol (Copenh) 1984;106:511-5
  18. Turnbull DM, Johnston DG, Alberti KG, Hall R. Hormonal and metabolic studies in a patient with a pheochromocytoma. J Clin Endocrinol Metab 1980;51:930-3 https://doi.org/10.1210/jcem-51-4-930
  19. Isles CG, Johnson JK. Phaeochromocytoma and diabetes mellitus: further evidence that alpha 2 receptors inhibit insulin release in man. Clin Endocrinol (Oxf) 1983;18:37-41 https://doi.org/10.1111/j.1365-2265.1983.tb03184.x
  20. Wiesner TD, Bluher M, Windgassen M, Paschke R. Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma. J Clin Endocrinol Metab 2003;88:3632-6 https://doi.org/10.1210/jc.2003-030000

Cited by

  1. Pheochromocytoma and Paraganglioma in Cyanotic Congenital Heart Disease vol.100, pp.4, 2008, https://doi.org/10.1210/jc.2014-3863
  2. Pheochromocytoma complicated by cyanotic congenital heart disease: a case report vol.25, pp.2, 2008, https://doi.org/10.1297/cpe.25.59
  3. Tetralogy of Fallot and pheochromocytoma in a situs inversus totalis: An unusual association vol.8, pp.3, 2016, https://doi.org/10.15171/jcvtr.2016.27
  4. Pheochromocytoma and paraganglioma in Fontan patients: Common more than expected vol.13, pp.4, 2008, https://doi.org/10.1111/chd.12625
  5. Abdominal imaging findings in adult patients with Fontan circulation vol.9, pp.3, 2008, https://doi.org/10.1007/s13244-018-0609-2
  6. Catecholamine-Secreting Tumors in Pediatric Patients With Cyanotic Congenital Heart Disease vol.3, pp.11, 2008, https://doi.org/10.1210/js.2019-00226